Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

NYSE: BHVN · IEX Real-Time Price · USD

38.97

+0.43 (1.12%)

At close: Apr 26, 2024, 4:00 PM

38.72

-0.25 (-0.64%)

After-hours: Apr 26, 2024, 7:54 PM EDT

BHVN Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	3,182	3,434	946	-
Market Cap Growth	-	262.97%	-	-
Enterprise Value	2,828	3,080	476	-73
PE Ratio	-8.41	-8.41	-1.66	-
PB Ratio	7.44	8.02	1.76	-
P/FCF Ratio	-10.26	-10.26	-3.11	-
P/OCF Ratio	-10.35	-10.35	-3.18	-
EV/EBITDA Ratio	-7.65	-7.65	-0.84	0.35
EV/EBIT Ratio	-7.52	-7.52	-0.84	0.34
EV/FCF Ratio	-9.20	-9.20	-1.57	0.50
Debt / Equity Ratio	0.06	0.06	0.06	0.08
Debt / EBITDA Ratio	-0.07	-0.07	-0.05	-0.01
Debt / FCF Ratio	-0.08	-0.08	-0.10	-0.02
Quick Ratio	6.89	6.89	5.56	1.81
Current Ratio	7.98	7.98	6.52	2.26
Return on Equity (ROE)	-103.50%	-103.50%	-198.90%	-830.70%
Return on Assets (ROA)	-80.80%	-80.80%	-141.90%	-168.60%
Return on Capital (ROIC)	-95.72%	-95.72%	-99.75%	-583.92%
Earnings Yield	-12.83%	-11.89%	-60.28%	-
FCF Yield	-10.52%	-9.75%	-32.11%	-
Buyback Yield / Dilution	-59.14%	-59.14%	-13.63%	-
Total Shareholder Return	-59.14%	-59.14%	-13.63%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).